[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
(X) Author agreement (has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!)) The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory. (https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf) (X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes. (X) Figure legends. Only text; before figures
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!
We would like to remind you that further action is required to complete the above referenced submission.
You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript.
When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.
Thank you for considering this journal, and we look forward to receiving your submission.
Kind regards, Phytomedicine
Technical comments (if applicable):
More information and support: You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors FA** How can I reset a forgotten password? https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/
For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.
__________________________________________________ In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions.
[GetPortalCommentsPageByObjectIdResponse(id=2150630, encodeId=1f2a215063098, content=修回后Under Editor Assessment半个多月了,可以发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Mon Jul 31 16:12:53 CST 2023, time=2023-07-31, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1193931, encodeId=145e11939317d, content=偏重的研究方向:中药药理<br>经验分享:记录一下投稿状态:<br>2022.01.05投稿<br>2022.01.07要求提供缩略词,但是这个我的正文里明明包括了<br>2022.01.09看到后重新修改提交<br>2022.01.13开始一直是reviewer invited的状态<br>2022.02.03 Under Review<br>2022.02.08 Required Reviews Completed<br>2022.02.10 又开始under review<br>2022.02.11 Required Reviews Completed<br>2022.02.14 under review<br>2022.02.15 Required Reviews Completed<br>这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8b76395580, createdName=ms1000001022052884, createdTime=Wed Feb 16 09:59:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向:中药单体<br>经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=2024-05-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131405, encodeId=6236213140557, content=想要询问一下以下情况如何解决:<br><br>(X) Author agreement<br>(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))<br>The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.<br>(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)<br>(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.<br>(X) Figure legends. Only text; before figures<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57318663160, createdName=ms1000001447770011, createdTime=Wed May 10 14:57:44 CST 2023, time=2023-05-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181152, encodeId=50c12181152b2, content=有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Sat Jan 13 10:35:30 CST 2024, time=2024-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2156128, encodeId=c0212156128b1, content=二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aed05086398, createdName=145c3ab9m71暂无昵称, createdTime=Tue Sep 05 06:37:40 CST 2023, time=2023-09-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2174386, encodeId=e0c421e438609, content=请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Dec 12 09:05:15 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208238, encodeId=467b120823814, content=求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!<br><br>We would like to remind you that further action is required to complete the above referenced submission.<br><br>You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript. <br><br>When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.<br><br>Thank you for considering this journal, and we look forward to receiving your submission.<br><br>Kind regards,<br>Phytomedicine<br><br>Technical comments (if applicable):<br><br><br>More information and support:<br>You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors<br>FA** How can I reset a forgotten password?<br> https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/<br><br>For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.<br><br>__________________________________________________<br>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Sat Apr 02 21:42:37 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向:中药;心血管<br>经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省)]
修回后Under Editor Assessment半个多月了,可以发邮件问一下吗
45
偏重的研究方向:中药药理
经验分享:记录一下投稿状态:
2022.01.05投稿
2022.01.07要求提供缩略词,但是这个我的正文里明明包括了
2022.01.09看到后重新修改提交
2022.01.13开始一直是reviewer invited的状态
2022.02.03 Under Review
2022.02.08 Required Reviews Completed
2022.02.10 又开始under review
2022.02.11 Required Reviews Completed
2022.02.14 under review
2022.02.15 Required Reviews Completed
这番操作我委实看不懂了,心慌,有没有前辈可以分享一下经验的o(╥﹏╥)o
81
偏重的研究方向:中药单体
经验分享:请问换编辑后with editor assessment要多久才能under review,已经十多天了😂
8
状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?
14
想要询问一下以下情况如何解决:
(X) Author agreement
(has to be uploaded as an extra file; Format: MS Word, TIF, EPS, … (not .pdf please!))
The author agreement form for this journal with all author signatures is required. The signature of corresponding author is mandatory.
(https://www.elsevier.com/__data/promis_misc/710660_aucc_author_agreement.pdf)
(X) Format: Acceptable text file formats include MS Word, Word Perfect, RTF, TEX or plain ASCII text. TIF and EPS files are preferred for figures. PDF, DVI and PS files are not acceptable for publishing purposes.
(X) Figure legends. Only text; before figures
0
有editor是广中医刘院士的吗?他处理稿件一直都很慢吗,with editor assessment已经40天了。
24
二审审稿人说已经修改但没有具体意见,编辑还给了修回,回复邮件编辑也不回,感觉跟之前的编辑好像不一样,这个不是很负责,根本没有看审稿人的意见
43
请问under editor assessment 状态会持续多久啊?已经10天了。感觉这个期刊对综述性文章太不友好了吧,submitted状态就持续了24天,编辑评估又这么多长时间,坑死了。
25
求问有人遇到过这个情况吗?投稿两天后,稿件被返回(send back to author),并收到以下邮件,邮件中并没有找到需要修改些什么的意见....这是被拒了吗?如果被拒了不应该是写着“reject”吗,邮件又像是让重新提交的意思。求大佬指点!
We would like to remind you that further action is required to complete the above referenced submission.
You have received this message for one of two reasons. Either: (a) your manuscript has been transferred from another journal and you must now complete your resubmission, or (b) technical comments (included below) need to be addressed before resubmitting your manuscript.
When you are ready to proceed with your submission, please log in as an author at https://www.editorialmanager.com/PHYMED/ and navigate to the "Submissions Sent Back to Author" folder. There you can edit your submission by clicking "Edit submission" under the "Action Link" menu.
Thank you for considering this journal, and we look forward to receiving your submission.
Kind regards,
Phytomedicine
Technical comments (if applicable):
More information and support:
You will find information relevant for you as an author on Elsevier’s Author Hub: https://www.elsevier.com/authors
FA** How can I reset a forgotten password?
https://service.elsevier.com/app/answers/detail/a_id/28452/supporthub/publishing/kw/editorial+manager/
For further assistance, please visit our customer service site: https://service.elsevier.com/app/home/supporthub/publishing/. Here you can search for solutions on a range of topics, find answers to frequently asked questions, and learn more about Editorial Manager via interactive tutorials. You can also talk 24/7 to our customer support team by phone and 24/7 by live chat and email.
__________________________________________________
In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Use the following URL: https://www.editorialmanager.com/PHYMED/login.asp?a=r). Please contact the publication office if you have any questions.
309
偏重的研究方向:中药;心血管
经验分享:请问大家,投稿半个月,状态一直是Submitted to Journal,这种情况正常吗,需要发邮件问一下吗
29